Hardy J - Search Results

1

Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.

Fossella FV, Lippman SM, Seitz DE, Alberts DS, Taylor CW, Wiltshaw E, Hardy J, O'Brien M, Haynes TR, Wolen RL. Fossella FV, et al. Among authors: hardy j. Invest New Drugs. 1991 Nov;9(4):357-9. doi: 10.1007/BF00183581. Invest New Drugs. 1991. PMID: 1804813 Clinical Trial. No abstract available.

2

A phase II study of sulofenur, a novel sulfonylurea, in recurrent epithelial ovarian cancer.

O'Brien ME, Hardy J, Tan S, Walling J, Peters B, Hatty S, Wiltshaw E. O'Brien ME, et al. Among authors: hardy j. Cancer Chemother Pharmacol. 1992;30(3):245-8. doi: 10.1007/BF00686324. Cancer Chemother Pharmacol. 1992. PMID: 1628377 Clinical Trial.

3

Cisplatin and carboplatin in combination for the treatment of stage IV ovarian carcinoma.

Hardy JR, Wiltshaw E, Blake PR, Harper P, Slevin M, Perren TJ, Tan S. Hardy JR, et al. Ann Oncol. 1991 Feb;2(2):131-6. doi: 10.1093/oxfordjournals.annonc.a057876. Ann Oncol. 1991. PMID: 2054315 Free article. No abstract available.

4

Malignant transformation of squamous elements within a dermoid cyst.

Hardy J, Fisher C, Wiltshaw E. Hardy J, et al. Gynecol Oncol. 1992 May;45(2):229-30. doi: 10.1016/0090-8258(92)90292-q. Gynecol Oncol. 1992. PMID: 1592294 No abstract available.

5

A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors.

Peacock NW, Burris HA, Dieras V, Smith L, Rodriguez GI, Eckardt JR, Jones SF, Hardy J, Hohneker J, Bigley J, Von Hoff DD. Peacock NW, et al. Among authors: hardy j. Invest New Drugs. 1998;16(1):37-43. doi: 10.1023/a:1016075126007. Invest New Drugs. 1998. PMID: 9740542 Clinical Trial.

6

Treatment of advanced ovarian cancer with intraperitoneal tumour necrosis factor.

Hardy J, Jones A, Gore ME, Viner C, Selby P, Wiltshaw E. Hardy J, et al. Eur J Cancer. 1990;26(6):771. doi: 10.1016/0277-5379(90)90146-k. Eur J Cancer. 1990. PMID: 2144175 No abstract available.

7

How nephrotoxic is carboplatin?

Hardy JR, Tan S, Fryatt I, Wiltshaw E. Hardy JR, et al. Br J Cancer. 1990 Apr;61(4):644. doi: 10.1038/bjc.1990.143. Br J Cancer. 1990. PMID: 2184881 Free PMC article. No abstract available.

8

Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812).

O'Rourke TJ, Weiss GR, New P, Burris HA 3rd, Rodriguez G, Eckhardt J, Hardy J, Kuhn JG, Fields S, Clark GM, et al. O'Rourke TJ, et al. Among authors: hardy j. Anticancer Drugs. 1994 Oct;5(5):520-6. doi: 10.1097/00001813-199410000-00002. Anticancer Drugs. 1994. PMID: 7858283 Clinical Trial.

9

Phase I clinical investigation of amonafide.

Saez R, Craig JB, Kuhn JG, Weiss GR, Koeller J, Phillips J, Havlin K, Harman G, Hardy J, Melink TJ, et al. Saez R, et al. Among authors: hardy j. J Clin Oncol. 1989 Sep;7(9):1351-8. doi: 10.1200/JCO.1989.7.9.1351. J Clin Oncol. 1989. PMID: 2549205 Clinical Trial.

10

Carboplatin dose optimization.

Pinkerton CR, Hardy JR. Pinkerton CR, et al. Among authors: hardy jr. J Clin Oncol. 1990 Jul;8(7):1283-5. doi: 10.1200/JCO.1990.8.7.1283. J Clin Oncol. 1990. PMID: 1694237 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,478 results

Search Page

Filters